Results 181 to 190 of about 6,234,447 (291)

Research participation

Academic Medicine, 1988
P B, Zeldow, S, Kleinerman
openaire   +3 more sources

Jonathan Durand Folco, Réinventer la démocratie : de la participation à l’intelligence collective, Ottawa, Presses de l’Université d’Ottawa, 2023, 120 p.

Benoit Genest
openalex   +1 more source

A Screening Tool to Enhance Clinical Trial Participation at a Community Center Involved in a Radiation Oncology Disparities Program

, 2011
J.W. Proctor, Elaine Martz, Larry L. Schenken, Rebecca Rainville, Ursula Marlowe   +4 more
openalex   +2 more sources

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Self-Experienced Difficulties in Communicative Participation in Children With Speech, Language and Communication Needs-A Concept Elicitation Study. [PDF]

Int J Lang Commun Disord
Alons E, Berndsen-van Swaaij B, Terwee C, Gerrits E, Luinge M, Ewijk LV.   +5 more
europepmc   +1 more source

GENDERED BARRIERS AND POLITICAL EXCLUSION: FEMALE STUDENTS' PARTICIPATION IN CAMPUS POLITICS AT THE UNIVERSITY OF PESHAWAR

Bushra Khan,Mujahid Khan,Nayab Bibi
openalex   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Predictors of Patient Participation in Pressure Injury Prevention: An Observational Substudy. [PDF]

Int Wound J
Chaboyer W, Walker R, Harbeck E, Latimer S, Cooke M, Gillespie BM.   +5 more
europepmc   +1 more source

Does Understanding the Kalamazoo Promise Impact African American Participation

, 2012
Jeremy D. Penn
openalex   +1 more source

Community Participation in the Development of Local Wisdom-Based Tourism Villages

Gustia Gustia, M. Ridwan Ahmad Said, Firdaus W Suhaeb   +2 more
openalex   +2 more sources